Morningside Venture Partners

Investor type Angel Group

Overview

Unlock datapoints

Portfolio analytics

Team

Investments

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.
Total investments 31
Average round size
info
The average size of a deal this fund participated in
$32M
Portfolio companies 26
Rounds per year 10.33
Lead investments 5
Follow on index
info
How often the fund supports its portfolio startups at next rounds
0.16
Exits 6
Key employees 1
Stages of investment
Early Stage Venture
Seed

Areas of investment

  • Biotechnology
  • Health Care
  • Medical
  • Therapeutics
  • Pharmaceutical
Summary

Morningside Venture Partners appeared to be the VC, which was created in 1986. The main department of described VC is located in the Shanghai. The venture was found in Asia in China.

The typical case for the fund is to invest in rounds with 3-4 participants. Despite the Morningside Venture Partners, startups are often financed by Providence Investment Company Limited, Nesta Ventures, UK Innovation & Science Seed Fund. The meaningful sponsors for the fund in investment in the same round are Providence Investment Company Limited, Takeda Ventures, Nesta Ventures. In the next rounds fund is usually obtained by Providence Investment Company Limited, Temasek Holdings, Takeda Ventures.

This organization was formed by Ronnie Chan. The overall number of key employees were 1.

Among the most popular portfolio startups of the fund, we may highlight Xiaomi, ENYO Pharma, Milk and Eggs. Besides, a startup needs to be aged 6-10 years to get the investment from the fund. For fund there is no match between the country of its foundation and the country of its the most frequent investments - United States. The fund has no exact preference in a number of founders of portfolio startups. If startup sums 3 or 4 of the founder, the chance for it to be financed is low.

This Morningside Venture Partners works on 12 percentage points less the average amount of lead investments comparing to the other organizations. The important activity for fund was in 2018. The fund is generally included in less than 2 deals every year. Speaking about the real fund results, this VC is 5 percentage points more often commits exit comparing to other organizations. The common things for fund are deals in the range of 10 - 50 millions dollars. The higher amount of exits for fund were in 2019. The typical startup value when the investment from Morningside Venture Partners is 10-50 millions dollars.

Read more

Related Funds

Funds investing in previous rounds
These funds often invest in the rounds preceeding the rounds of Morningside Venture Partners:
Typical Co-investors
Morningside Venture Partners is more likely to invest in rounds together with the following funds:
Funds investing in following rounds
These funds have a tendency to invest in the following rounds after Morningside Venture Partners:
1 Bose

Funds with similar focus

Funds from United States
Funds with similar focus located in United States:
Funds with the same geo focus
Funds with similar geography of portfolio companies:
Funds doing lead investments
Funds with similar focus acting as lead investors:

Look at other 50 related and similar funds Collapse list
Fund NameLocation
American-Value Fund -
Amtech California, San Francisco, United States
APAMAN Japan, Tokyo
Fullerton Financial Holdings Central Region, Singapore, Singapore
JC Management -
KSP investment fund -
KYMCO Capital China, Fujian, Taipei
Lagunita BioSciences LLC California, Menlo Park, United States
LEO Group China, Wenling, Zhejiang
Mantra Investment Partners -
Matsuo Sangyo Japan, Osaka, Osaka Prefecture
MIT Media Lab Cambridge, Massachusetts, United States
Neoteny 4 -
Sage Hill Partners, LLC -
University of Waterloo Canada, Ontario, Waterloo
Venturi Group Minnesota, Saint Paul, United States
Xiamen Fenghuang Huaji China, Fujian, Xiamen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

Prilenia

Biotechnology
Pharmaceutical
$43M03 Nov 2021 Boston, Massachusetts, United States

Exo Therapeutics

Biotechnology
Health Care
Pharmaceutical
$78M05 Oct 2021 Cambridge, Massachusetts, United States

Advertising
Artificial Intelligence
Machine Learning
SaaS
Software
$30M08 Apr 2021 Boston, Massachusetts, United States

Tallac Therapeutics

Biotechnology
Health Care
Therapeutics
$62M01 Dec 2020 California, United States

Gracell Biotechnologies

Biotechnology
Health Care
Medical
$100M28 Oct 2020 Gusu District, Jiangsu, China

InCarda Therapeutics

Biotechnology
Health Diagnostics
Therapeutics
$30M21 Oct 2020 California, United States

F2G

Biotechnology
Genetics
Health Care
Medical
Pharmaceutical
$60M12 Aug 2020 Manchester, England, United Kingdom

Greenlight Biosciences

Agriculture
AgTech
Biotechnology
Chemical
Fuel
Sustainability
$102M16 Jun 2020 Massachusetts, United States

Atea Pharmaceuticals

Biopharma
Biotechnology
Health Care
Pharmaceutical
$215M20 May 2020 Boston, Massachusetts, United States
News
Alyce Raises $30M in Series B Funding

– Alyce is a Boston, MA-based provider of a Personal Experience (PX) platform.
– Company raised $30m in Series B funding.
– The round was led by General Catalyst with participation from incumbent investors Manifest, Morningside, Boston Seed Capital, Golden Ventures, and Victress Capital.
– In conjunction with the funding, General Catalyst‘s Executive-in-Residence Lou Shipley joined Alyce’s board and Managing Partner Larry Bohn will become a board observer.
– The company intends to use the funds to accelerate growth through R&D, hiring, increased sales and customer support.

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent Morningside Venture Partners?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!

Wait!
You can raise money with us faster

Get matched with relevant funds

Find decision makers data

Connect with investors by email

Remind me later
...and save more than 200 hours*
*-Our recommendation and outreach system saves up to 200 hours of founder time on fundraising for seed and series A+ startups
We use LinkedIn only to verify your account. We don't import or message your contacts, nor post on your behalf.
By creating an account, you agree to our Terms of Service and Privacy Policy.
Crunchbase icon

Content report

The following text will be sent to our editors: